Prolacta Bioscience Opens An Expanded Facility In Industry, California
10/17/2013
The freezer at the new facility stands at 115,560 square foot, which will provide controlled frozen storage capacity for more than 110,000 liters of breast milk. The complex also includes two ISO 8 and one ISO 7 clean rooms totaling over 10,000 square feet.
Prolacta CEO Scott Elster said,"We now have a facility that can provide human milk nutritional products for every Neonatal Intensive Care Unit in the U.S. As hospitals continue to transition to exclusive human milk diets in their NICU, we are positioned to meet their needs by providing fortifier, pasteurized milk, and ready-to-feed products, all free of any cow milk or cow milk proteins.”
"Prolacta stands alone in being able to provide NICUs with a complete line of human milk formulations to meet the needs of critically ill premature infants," Elster added. "We are proud to be the first and only company to make human milk nutritional products that will be of such a significant benefit for premature infants."
Project Announcements
AESC Expands Florence, South Carolina, Operations
03/28/2024
Alticor Expands Ada Township, Michigan, Operations
03/27/2024
Eastman Plans Longview, Texas, Production Operations
03/27/2024
DHL Supply Chain-Vantage Data Centers NV11 Plan Nevada Operations
03/26/2024
Big Jet Expands Pittsburgh, Pennsylvania, Operations
03/26/2024
Landmark Ceramics UST Expands Mt. Pleasant, Tennessee, Operations
03/25/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Logistics Analysis That Drives Industrial Site Selection
Q4 2023
-
Manufacturing Momentum Is Building
Q1 2024
-
Technology’s Influence on Workforce Development
Workforce Q4 2023
-
38th Annual Corporate Survey: Are Unrealized Predictions of an Economic Slump Leading Small to Mid-Size Companies to Put Off Expansion Plans?
Q1 2024
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023